| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |